The 66 references in paper A. Smirnov V., V. Dobronravov A., I. Kayukov G., А. Смирнов В., В. Добронравов А., И. Каюков Г. (2005) “КАРДИО-РЕНАЛЬНЫЙ КОНТИНУУМ: ПАТОГЕНЕТИЧЕСКИЕ ОСНОВЫ ПРЕВЕНТИВНОЙ НЕФРОЛОГИИ // CARDIORENAL CONTINUUM, PATHOGENETICAL GROUNDS OF PREVENTIVE NEPHROLOGY” / spz:neicon:nefr:y:2005:i:3:p:7-15

1
Смирнов АВ, Каюков ИГ, Есаян АМ, Добронравов ВА, Кучер АГ, Тугушева ФА. Превентивный подход в современной нефрологии. Нефрология 2004; 8(3): 7-14
(check this in PDF content)
2
Perera GA. Hypertensive vascular disease: description and natural history. J Chron Dis 1955; 1: 33-42
(check this in PDF content)
3
Кузьмин ОБ, Пугаева МО, Чуб СВ. Легкая дисфункция почек у больных с эссенциальной гипертонией: клинические проявления и лекарственная терапия. Нефрология 2004; 8(3): 15-21
(check this in PDF content)
4
Смирнов АВ, Есаян АМ, Каюков ИГ. Хроническая болезнь почек: на пути к единству представлений. Нефрология 2002; 6(4): 11-17
(check this in PDF content)
5
National Kidney Foundation KD: Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S1-S266
(check this in PDF content)
6
Ruelope ZM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-225
(check this in PDF content)
7
Brown MJ, Palmer CR, Castaigne A et al. Morbidity and mortality in patients randomized to double-blind treatment with long-acting calcium-channel blocker or diuretic in International Nifidipine GITS study: Intervention as a goal in Hypertension Treatment (INSIGHT). Lancet 2000: 356 (9228): 366-372
(check this in PDF content)
8
Haroun NK, Jaar BG, Hoffman SC et al. Risk factors for chronic kidney disease: a prospective study of 23.534 men and women in Washington Country, Maryland. J Am Soc Nephrol 2003; 14: 2934- 2941
(check this in PDF content)
9
U.S. Renal Data System. USDRS 2001. Annual Data Report, Bethesda, M.D., National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2001
(check this in PDF content)
10
Ritz E, Dikow R, Ruilope LM. Renal dysfunction as a cardiovascular risk factor. Curr Hypertens Rep 2002; 4: 365368
(check this in PDF content)
11
Смирнов АВ, Добронравов ВА, Бодур-Ооржак АШ и др. Эпидемиология и факторы риска хронических болезней почек: региональный уровень общей проблемы. Тер арх 2005; 77(6): 20-27
(check this in PDF content)
12
Halimi JM, Forhan A, Balkan B et al. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women? J Cardiovasc Risk 2001; 8: 139- 146
(check this in PDF content)
13
Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663- 1672
(check this in PDF content)
14
Stuveling EM, Bakker SJ, Hilige HX et al. Biochemical risk markers: a novel area for better prediction of renal risk? Nephrol Dial Transplant 2005; 20: 497- 508
(check this in PDF content)
15
Zavie CJ, Milani RV. Obesity and cardiovascular disease: the Hyppocrates paradox? J Am Coll Cardiol 2003; 42: 677- 679
(check this in PDF content)
16
Kalantar- Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 48: 1439- 1444
(check this in PDF content)
17
Stendel B, Tarver-Carr ME, Powe NR et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14: 479- 487
(check this in PDF content)
18
Краснова ЕА, Моисеев СВ, Фомин ВВ. Нефрологические аспекты проблемы ожирения. Клин мед 2005; 83 (4): 9- 14
(check this in PDF content)
19
Kambham N, Markowitz GS, Valeri AM et al. Obesityrelated glomerulopathy: an emerging epidemic. Kidney Int 2001; 59: 1498- 1509
(check this in PDF content)
20
Jong PE, Verhave JC, Pinto- Siestma SJ et al. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 2002; 26 [Suppl 4]: S21- S24
(check this in PDF content)
21
Verhave JC, Hillege HZ, Burgerhof GM et al. The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005; 67: 19671973
(check this in PDF content)
22
Pinto- Siersma SJ, Mulder J, Janssen WM et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000; 133: 585- 591
(check this in PDF content)
23
Klag MJ, Whelton PK, Randall BZ et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18
(check this in PDF content)
24
Fried ZF, Orchard TJ, Kasiske BZ. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260- 269
(check this in PDF content)
25
Schaeffner ES, Kurth T, Curhan GC et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003; 14: 2084- 2091
(check this in PDF content)
26
Muntner P, Coresh J, Smith JC et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000; 58: 293- 301
(check this in PDF content)
27
Crundy SM, Brewer HB, Cluman JI et al. Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute. American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433- 438
(check this in PDF content)
28
Pinto- Siersma SJ, Navis G, Janssen WM et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003; 41: 733-741
(check this in PDF content)
29
Salmennienmi U, Ruotsalainen E, Philajamaki J et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004; 110: 3842- 3848
(check this in PDF content)
30
Chen J, Munter P, Hamm LZ et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-174
(check this in PDF content)
31
Linder A, Charka B, Sherrazd DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 679- 701
(check this in PDF content)
32
U.S. Renal Data System. USRDR 2000 Annual Data Report, Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2000.
(check this in PDF content)
33
Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 [Suppl 12]: S16- S23
(check this in PDF content)
34
Смирнов АВ, Добронравов ВА, Румянцев АШ, Мнускина ММ. Факторы риска ИБС у больных, получающих лечение гемодиализом. Нефрология 2002; 7 [Прил 1]: 7- 13.
(check this in PDF content)
35
Кутырина ИМ, Руденко ТЕ, Дзигоева МЮ. Ремоделирование сосудов при хронической почечной недостаточности. Клин мед 2005; 2: 16- 21
(check this in PDF content)
36
U.S. Renal Data System. USRDR 2000 Annual Data Report: Atlas of end-stage renal disease in the United States. Bethseda. MD, National Institutes of Health. 2003; 1- 560
(check this in PDF content)
37
Bongartz LG, Cramer MJ, Doevendans PA et al. The severe cardiorenal syndrome: «Guyton revisited». Eur Heart J 2005; 26: 11- 17
(check this in PDF content)
38
Majunath G, Tighionart H, Corest F. Level of kidney function as a risk factors for cardiovascular outcomes in the elderly. Kidney Int 2003; 63: 1121- 1129
(check this in PDF content)
39
Majunath G, Tighionart H, Ibrahim H et al. Level of Kidney function as a risk factors for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003; 41: 47- 55
(check this in PDF content)
40
Henry RM, Kostense PJ, Bos G et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002; 62: 1402- 1407
(check this in PDF content)
41
Al Ahmad A, Rand WM, Manjunath G et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955- 962
(check this in PDF content)
42
Sorensen CR, Brendorp Brask-Madsen C et al. The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 2002; 23: 948-952
(check this in PDF content)
43
Anavekar NS, Me Murray JV, Velazguez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 13
(check this in PDF content)
44
Anavekar NS, Pfeffer MA. Cardiovascular risk in chronic kidney disease. Kidney Int 2004; 66 [Suppl 92]: S11- S15
(check this in PDF content)
45
Al Suwaidi J, Reddan DN, Williams K et al. GUSTO- IIb, GUSTO-III, PURSUIT, and PARAGON-A Investigators: Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974- 980
(check this in PDF content)
46
Gibson CM, Pinto DS, Murphy SA et al. TIMI Study Group: Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003; 42: 1535- 1543
(check this in PDF content)
47
Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol Dial Transplant 2002; 17 [Suppl 11]: 50- 54
(check this in PDF content)
48
Mourad JJ, Pannier B, Blacher J et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001; 59: 1834- 1841
(check this in PDF content)
49
Safar ME, Henry O, Meanme S. Aortic pulse wave velocity: an independent marker of cardiovascular risk. Am J Geriatr Cardiol 2002; 11: 295- 298
(check this in PDF content)
50
Goldsmith D, MacGinley R, Smith A, Covic A. How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure? Nephrol Dial Transplant 2002; 17: 965- 969
(check this in PDF content)
51
Sarnak MJ, Cornado BE, Greene T et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002; 57: 327- 335
(check this in PDF content)
52
Смирнов АВ. Уремическая дислипопротеинурия. Нефрология 1998; 2(1): 15-21
(check this in PDF content)
53
Смирнов АВ, Добронравов ВА, Голубев РВ и др. Распространенность гипергомоцистеинемии в зависимости от стадии хронической болезни почек. Нефрология 2005; 9(2): 48-52
(check this in PDF content)
54
Owen WF, Zowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998; 54: 627- 636
(check this in PDF content)
55
Zimmerman J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648- 658
(check this in PDF content)
56
Schindler R, Boenish O, Fisher C, Frei U. Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol 2000; 53: 452
(check this in PDF content)
57
Pertosa G, Gesuado Z, Boftalico D, Schena EP. Endotoxins modulate chronically tumor necrosis factor alpha and interleukin 6 release by uremia monocytes. Nephrol Dial Transplant 1995; 10: 328- 333
(check this in PDF content)
58
Menon V, Wang X, Green T et al. Relation skip between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 2003; 42: 44- 52
(check this in PDF content)
59
Friedman EA. Advanced glucation end products diabetic nephronaphy. Nephrol Dial Transplant 1999; 14 [Suppl 3]: S1
(check this in PDF content)
60
Zingo G, Biasucci ZM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417- 424
(check this in PDF content)
61
Arein M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001; 59: 407- 414
(check this in PDF content)
62
Zindholm B, Heimburger Q, Stenvinkel P. What are the causes of protein – energy malnutrition in chronic renal insufficiency? Am J Kidney Dis 2002; 39: 422- 425
(check this in PDF content)
63
Ward R, Me Zeish K. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 1995; 5: 1697- 1702
(check this in PDF content)
64
Steinberg D, Parthasarathy S, Carew TE et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 916- 924
(check this in PDF content)
65
Hegarty J, Foley RN. Anaemia, renal insufficiency and cardiovascular outcome. Nephrol Dial Transplant 2001; 16 [Suppl 1]: 102- 104
(check this in PDF content)
66
Friedman AN, Boston AG, Selhub J et al. The kidney and homocysteine metabolism. J Am Soc Nephrol 2001; 12: 2181- 2189 Ïîñòóïèëà â ðåäàêöèþ 18.06.2005 ã.
(check this in PDF content)